Medical Care in China

tuberculosis
Treatment in China

Provide a clear and complete coordinated pathway from expert assessment to treatment and rehabilitation.

Get a Care Plan and Cost Estimate
Multidisciplinary internal medicine resources, includingrespiratory, infectious diseases, immunology, and endocrinology, provide collaborative diagnosis and treatment.
Complex Chronic Disease ManagementLong-term management of multiple chronic diseases.
Difficult disease diagnosishelps find the cause of unexplained fever and complex immune diseases.
Personalized long-term managementcombines medication, lifestyle, and rehabilitation for continuous management.

Condition Guide

About tuberculosis

Understand the condition, common triggers and treatment options that may require specialist assessment.

Disease Introduction

Pulmonary tuberculosis is a chronic respiratory infectious disease caused by Mycobacterium tuberculosis, commonly known as "consumption." Its main symptoms include persistent cough with sputum or blood in the sputum, afternoon low-grade fever, night sweats, and weight loss. It is classified into newly diagnosed and drug-resistant tuberculosis . The core of treatment is regular, combined, and complete use of anti-tuberculosis drugs; with standardized treatment, the vast majority of cases can be cured.


Cutting-edge high-precision diagnostic and treatment technologies

  1. BPaL short-course oral regimen : Bedaquiline + Putomomani + Linezolid for 6 months, a short-course all-oral regimen recommended by Chinese expert consensus in 2025, with a cure rate of over 90% for drug-resistant tuberculosis.
  2. Putomomani to be launched in China : The new anti-tuberculosis drug Putomomani will be officially launched in China in January 2025. It will form the BPaL regimen with bedaquiline and linezolid, bidding farewell to the era of injection.
  3. BPaLM Quadruple Short-Term Treatment : BPaLM is composed of BPaL plus moxifloxacin. The 2025 consensus recommends it as the first-line treatment for fluoroquinolone-sensitive or unknown rifampicin-resistant tuberculosis.
  4. Rapid molecular drug sensitivity diagnosis : The 2025 WHO diagnostic guidelines list Xpert MTB/RIF and Xpert XDR as first-line initial diagnoses, and rifampicin resistance can be detected simultaneously within 2 hours.
  5. Combined molecular detection of BALF : Combined detection of bronchoalveolar lavage fluid with GeneXpert, PCR and NTM-PCR significantly improves the etiological diagnostic rate of sputum smear negative and sputum-free pulmonary tuberculosis.

Care Overview

tuberculosis Treatment in China

The medical team will develop a personalized protocol based on the pathology type, stage, genetic test, previous treatment history, and the patient's physical condition.

Leading Specialists

Trusted Expertise Across Leading Specialties

Yang Chengde

Chief Physician, Doctoral Supervisor, Department Director

Internal Medicine

-Research areas : antiphospholipid syndrome, systemic lupus erythematosus, adult-onset Still's disease, autoimmune disease-related thrombosis. - Cutting-edge technologies: Construction of APS risk stratification model; Mining of AOSD susceptibility genes and biomarkers; Co-management system for immune thrombosis and pregnancy-related rheumatism. - Areas of expertise: Systemic lupus erythematosus, antiphospholipid syndrome, adult-onset Still's disease, rheumatoid arthritis, and complex rheumatic diseases w

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine logo Affiliated Hospital Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Liu Xiaoqing

Infection and Evidence-Based Medicine in Immunocompromised Populations

Internal Medicine

Research areas: Diagnosis and differential diagnosis of febrile diseases, diagnosis and treatment of various infectious diseases (especially hepatitis, tuberculosis, and complicated infections), and selection and application of antibacterial drugs. Cutting-edge technology: Pioneered the focus in China on the high risk of tuberculosis in patients with rheumatic and immunological diseases, leading a multicenter cross-sectional study investigating the prevalence of active tuberculosis in Chinese patients wit

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences logo Affiliated Hospital Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Ye Hui

Infectious Disease Center Experts

Internal Medicine

Research areas : various types of acute and chronic hepatitis , central nervous system infections, respiratory tract infections, bloodstream infections, skin and soft tissue infections; rational use of antimicrobial drugs; drug-resistant bacterial infections; fever pending diagnosis. Areas of expertise: various liver diseases, central nervous system infections, respiratory tract infections, digestive tract infections, urinary tract infections, bloodstream infections, skin and soft tissue infections, and f

West China Hospital of Sichuan University logo Affiliated Hospital West China Hospital of Sichuan University
Liu Zhengyin

Difficult and severe infections and fungal infections

Internal Medicine

Research areas: Nosocomial infections (infections caused by various pathogens, including various opportunistic infections in AIDS patients), epidemiology and drug treatment of fungal infections, and clinical pharmacology of anti-infective drugs. Cutting-edge technology: Possesses comprehensive knowledge of the diagnosis and treatment of common and frequently occurring infectious diseases, and is skilled in the diagnosis and treatment of various pathogen infections, especially various difficult and severe

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences logo Affiliated Hospital Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Xie Qing

Chief Physician, Level 2 Professor, Doctoral Supervisor, Director of the Department of Infectious Diseases

Internal Medicine

-Research areas : viral hepatitis, liver failure, cirrhosis, clinical cure of chronic hepatitis B, drug-induced liver disease. - Cutting-edge technologies: Clinical cure program for chronic hepatitis B RGT; prognostic early warning model for liver failure; artificial liver combined with comprehensive internal medicine treatment. - Areas of expertise: Chronic hepatitis B/C, acute-on-chronic liver failure, cirrhosis, comprehensive management of liver cancer and other liver diseases, and drug-induced liver i

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine logo Affiliated Hospital Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Sun Xiaohong

Professor , Chief Physician of the Department of Geriatrics, and Vice Chairman of the Geriatrics Specialist Branch of the Beijing Medical Association.

Internal Medicine

Research areas: Comprehensive diagnosis and treatment of common geriatric diseases, identification and management of geriatric syndromes, and health management and disease prevention for the elderly. Cutting-edge technology: As the deputy director (in charge) of the Department of Geriatrics, I led the department's daily clinical management and outpatient system optimization, promoting the standardized operation of specialized outpatient clinics such as the comprehensive geriatric outpatient clinic and the

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences logo Affiliated Hospital Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

Patient Stories

See the Next Step Through Patient Journeys

Methylmalonic acidemia - Deciphering the CASE 01
PATIENT JOURNEY

Methylmalonic acidemia - Deciphering the "metabolic code" to help "special" babies grow normally.

Internal MedicinePediatrics

Patient records: Name: Mei Ling Age: 3 months Nationality: Malaysia Diagnosis: Methylmalonic acidemia (MMA), combined type Treatment Hospital: Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Decoding Genetic Defects: A Lifelong Battle for Precision Nutrition Meiling was born in Kuala Lumpur, Malaysia. Shortly after birth, she began experiencing recurrent vomiting, lethargy, and feeding difficulties, and quickly developed metabolic acidosis and severe anemia. Local hospitals

View case details →
Obesity and Metabolic Syndrome : A Saudi Businessman's Weight Loss Journey: How We Helped Him Find the Key to Controlling Diabetes in China CASE 02
PATIENT JOURNEY

Obesity and Metabolic Syndrome : A Saudi Businessman's Weight Loss Journey: How We Helped Him Find the Key to Controlling Diabetes in China

Internal Medicine

Patient records Name: Omar Age: 42 Nationality: Saudi Arabia Diagnosis: Severe obesity (BMI 42 kg/m²), metabolic syndrome (type 2 diabetes, hypertension, hyperlipidemia, severe obstructive sleep apnea) Treatment Hospital: Metabolic Weight Loss Center, China-Japan Friendship Hospital For patients with severe obesity and metabolic syndrome, weight loss is not just about "getting thinner," but about "saving lives." Omar's story tells how, through a minimally invasive surgery in China, he not only lost exces

View case details →

Next Step

Get a Care Plan
and Cost Estimate.

Tell us about your diagnosis and needs, and our team will help screen the right hospital and explain the next steps.

Email:goldentcm@163.com

Get a Care Plan and Estimate

Once you submit your information, a member of our support team will reach out to you within one business day.